Micropathological changes that contribute to reduced GMV in patients with MDD include atrophy of neurons, dendritic cells, and glial cells [36], while the molecular mechanisms involve increased expression of inflammatory mediators, mitochondrial dysfunction, and decreased levels of brain-derived neurotrophic factor (BDNF) [37, 38]. Here, BDNF is linked to major depressive disorder.